GI
LEGN icon

GAMMA Investing’s Legend Biotech LEGN Stock Holding History

GAMMA Investing’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
616
+241
+64% +$6.5K ﹤0.01% 2896
2026
Q1 		$6.78K Buy
375
+317
+547% +$6.04K ﹤0.01% 3248
2025
Q4 		$1.26K Sell
58
-1,095
-95% -$31.4K ﹤0.01% 3728
2025
Q3 		$37.6K Buy
1,153
+308
+36% +$11.4K ﹤0.01% 2169
2025
Q2 		$30K Sell
845
-446
-35% -$14.5K ﹤0.01% 2251
2025
Q1 		$43.8K Buy
1,291
+765
+145% +$27.4K ﹤0.01% 1884
2024
Q4 		$17.1K Buy
526
+104
+25% +$4.31K ﹤0.01% 2351
2024
Q3 		$20.6K Buy
422
+167
+65% +$8.89K ﹤0.01% 2088
2024
Q2 		$11.3K Buy
255
+77
+43% +$3.55K ﹤0.01% 2184
2024
Q1 		$9.98K Buy
178
+113
+174% +$6.82K ﹤0.01% 2071
2023
Q4 		$3.58K Buy
+65
New +$4.12K ﹤0.01% 2373

Other funds holding LEGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FHC
First Horizon Corporation Memphis, Tennessee $2.6B AUM 23.72% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return

GAMMA Investing's LEGN Position: Q2 2026 in Review

GAMMA Investing increased its Legend Biotech (LEGN) stake by 64% in Q2 2026, buying an estimated $6.5K and bringing the position to 616 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2896.

GAMMA Investing first reported a position in LEGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $43.8K in Q1 2025. 16 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • GAMMA Investing held 616 shares of Legend Biotech worth $17.8K as of Q2 2026.
  • GAMMA Investing bought 241 Legend Biotech shares in Q2 2026, an estimated $6.5K.
  • Legend Biotech made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2896 holding.
  • GAMMA Investing first reported a position in Legend Biotech in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Legend Biotech position peaked at $43.8K in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.